Pendium
Pricing
Get a demo
Dashboard
Dashboard
Loading…
/

Teach AI agents to recommend your brand to the right people.

Scan your visibilityBook a demo
Pendium
𝕏

Product

AI Visibility ScanYelp Listing AuditSite AuditContent for AI AgentsAgent Experience EngineAgent AnalyticsPricing

Industries

Local BusinessesRestaurantsHome ServicesBeauty & SpasHealth & MedicalFitness & GymsPet ServicesContractorsBars & NightlifeMoving CompaniesAuto DealershipsSaaS CompaniesSEO TeamsMarketing Teams

Tools

AI Visibility Site ScanYelp Listing AuditGBP AuditSocial Presence AuditBlog That Writes Itself

Real Life Examples

RipplingMasterclassThorneMonday.comPatagonia

Company

AboutBook a DemoDocsPrivacy PolicyTerms of Service
© 2026 Manifest Labs. All rights reserved.
PrivacyTerms
CellType
CellType
Visibility14
Vibe79
Businesses/Biotechnology/CellType
CellType
AI Visibility & Sentiment

CellType

CellType is a biotechnology company that uses AI foundation models trained on human cell data to simulate drug response in human biology. Their technology helps pharmaceutical companies prioritize drug targets, predict toxicity, and accelerate clinical trials before testing on actual patients.

Active Monitoring
celltype.com
BiotechnologyYC25-26
AI Visibility Score
14/100

Invisible

Sentiment Score
79/100
Score by Priority

How often this business is recommended to users across different types of conversations — from direct product queries to broader open-ended conversations where AI could recommend this company's products and services

core
14
adjacent
15
aspirational
9
OverviewLandscapeInsights & ActionsConversationsCitationsBrand Voice

Is this your business?

AI Perception

Key Takeaways

How AI platforms collectively perceive and describe CellType today.

CellType is currently a ghost in the AI discovery engines used by high-stakes pharma executives, failing to appear in any queries for the R&D persona despite maintaining a narrow technical foothold on Claude. While industry giants like Schrödinger and Exscientia dominate the 'top player' lists that drive enterprise partnerships, CellType's 0% visibility on ChatGPT and AI Overviews represents a critical failure in the brand's digital authority.

Working in your favor

Significant resonance within Claude, achieving a 42% mention rate and reaching the #1 position for brand-specific vibe checks.

Developing a niche presence with Technical Computational Biologists (40% visibility) and Clinical Safety Leads (36%), particularly for simulation-related queries.

High sentiment scores when mentioned, indicating that while the brand is hard to find, the information available is viewed favorably.

Gaps to close

Complete invisibility on ChatGPT and AI Overviews for all functional and category-based queries.

Zero penetration with the High-Stakes Pharma R&D Executive persona, a critical demographic for high-value biotech partnerships.

Absence from high-intent queries regarding 'top players' and 'evaluating AI biotech partners,' leaving the field open to competitors like Schrödinger and BenevolentAI.

Opportunities

Capture the 'de-risking drug targets' narrative where Claude is already showing early-stage recognition for the brand.

Infiltrate the 'Foundation Models' discourse by publishing technical benchmarks that AI crawlers can index for ChatGPT and Gemini.

Bridge the gap between technical niche recognition and executive-level authority to move from a #13 position to a top-tier recommendation.

Highest-Impact Actions
1

Execute a 'De-risking' Content Authority Campaign

CellType is currently missing from every query related to 'de-risking drug targets,' a core industry pain point where competitors are currently defining the standard.

2

Optimize for ChatGPT and AI Overview indexing via structured technical documentation

With 0% visibility on these platforms, the brand is effectively non-existent for users who rely on these tools for market mapping and vendor discovery.

3

Develop Executive-Level Whitepapers on AI Toxicity Prediction

The Clinical Safety Lead persona shows interest in CellType, but the brand lacks the authoritative content needed to climb from an average position of 7.8 into a top-3 recommendation.

Value Proposition

Simulate drug response in human biology before the first patient, enabling pharma companies to prioritize what to test and accelerate what works while catching toxicity signals that animal models miss.

Overview

CellType is a biotechnology company that uses AI foundation models trained on human cell data to simulate drug response in human biology. Their technology helps pharmaceutical companies prioritize drug targets, predict toxicity, and accelerate clinical trials before testing on actual patients.

Mission

Know how your drug works in humans before the first patient.

Products & Services
Target De-risking - virtual compound screening and target rankingTranslation & Toxicity Prediction - human adverse reaction prediction from preclinical dataClinical Acceleration - virtual patient stratification and responder identificationBiomarker Discovery - assay-ready biomarkers for go/no-go decisionsDiagnostics & Precision Health - multimodal biological data foundation models
Current State

Visibility Landscape

A high-level view of how CellType performs across AI platforms, broken down by strategic priority level — from core brand queries to growth opportunities.

ChatGPTChatGPT
ClaudeClaude
GeminiGemini
AI OverviewsAI Overviews

Reputation1q

Brand recognition & direct queries

70
97
70
97
“What do you know about CellType? What do they do and what's their reputation?”
Yes
#1
Yes
#1

Core2q

Product/service category queries

0
47
44
0
“how can i use foundation models to screen virtual compounds more effectively”
No
#6
#7
No
“ways to simulate human cell response for target ranking, any specific platforms i should check out?”
No
No
No
No

Growth Areas3q

Adjacent, aspirational & visionary

0
74
47
0
“help me find ways to de-risk drug targets using AI before moving to animal studies”
No
#6
#11
No
“how to predict human adverse reactions better than preclinical animal data”
No
#8
#19
No
“who are the top players in AI-driven drug discovery right now besides recursion or insitro”
No
#12
No
No
ChatGPT
Claude
Gemini
AI Overviews

“What do you know about CellType? What do they do and what's their reputation?”

ChatGPTYes
Claude#1
GeminiYes
AI Overviews#1

“how can i use foundation models to screen virtual compounds more effectively”

ChatGPTNo
Claude#6
Gemini#7
AI OverviewsNo

“ways to simulate human cell response for target ranking, any specific platforms i should check out?”

ChatGPTNo
ClaudeNo
GeminiNo
AI OverviewsNo

“help me find ways to de-risk drug targets using AI before moving to animal studies”

ChatGPTNo
Claude#6
Gemini#11
AI OverviewsNo

“how to predict human adverse reactions better than preclinical animal data”

ChatGPTNo
Claude#8
Gemini#19
AI OverviewsNo

“who are the top players in AI-driven drug discovery right now besides recursion or insitro”

ChatGPTNo
Claude#12
GeminiNo
AI OverviewsNo
Competitive Landscape
1
Schrödinger
24 mentions
2
Exscientia
19 mentions
3
BenevolentAI
18 mentions
4
Insilico Medicine
16 mentions
5
Emulate
15 mentions
6
Atomwise
14 mentions
7
Recursion
14 mentions
8
Insitro
14 mentions
9
AlphaFold
11 mentions
10
MIMETAS
9 mentions
11
CellType
8 mentions
Analysis

Insights & Recommended Actions

What's working, what's not, and specific steps to improve CellType's AI visibility.

Key Findings

Strength

Significant resonance within Claude, achieving a 42% mention rate and reaching the #1 position for brand-specific vibe checks.

Strength

Developing a niche presence with Technical Computational Biologists (40% visibility) and Clinical Safety Leads (36%), particularly for simulation-related queries.

Strength

High sentiment scores when mentioned, indicating that while the brand is hard to find, the information available is viewed favorably.

Recommended Actions

1

Execute a 'De-risking' Content Authority Campaign

CellType is currently missing from every query related to 'de-risking drug targets,' a core industry pain point where competitors are currently defining the standard.

2

Optimize for ChatGPT and AI Overview indexing via structured technical documentation

With 0% visibility on these platforms, the brand is effectively non-existent for users who rely on these tools for market mapping and vendor discovery.

3

Develop Executive-Level Whitepapers on AI Toxicity Prediction

The Clinical Safety Lead persona shows interest in CellType, but the brand lacks the authoritative content needed to climb from an average position of 7.8 into a top-3 recommendation.

Programmatic Testing

Sample Conversations

We programmatically analyze questions that real customers are asking to AI agents and chatbots, extract brand mentions and sentiment, analyze every response, and synthesize the data into an action plan to increase AI visibility.

ChatGPTChatGPTClaudeClaudeGeminiGeminiAI OverviewsAI Overviews
De Risking Drug Discovery And Early Screening(3 queries)

“help me find ways to de-risk drug targets using AI before moving to animal studies”

0/4 platforms mentioned

Adjacent
ChatGPTChatGPT
1.TwoSampleMR
2.MR-Base
3.coloc
4.SMR/HEIDI
5.gnomAD

+81 more

ClaudeClaude
1.Exscientia
2.Recursion
3.BenevolentAI
4.Insitro
5.AlphaFold

+19 more

GeminiGemini
1.BenevolentAI
2.Causaly
3.Owkin
4.AlphaFold2
5.DeepMind

+14 more

AI OverviewsAI Overviews
1.DeepTox
2.Owkin
3.CellProfiler
4.DrugBank
5.SIDER

+1 more

“how can i use foundation models to screen virtual compounds more effectively”

0/4 platforms mentioned

Core
The High-Stakes Pharma R&D Executive · VP of Early Discovery
ChatGPTChatGPT
1.ESM
2.ProtBERT
3.AlphaFold2
4.ESMFold
5.ChemBERTa

+25 more

ClaudeClaude
1.DeepChem
2.BenevolentAI
3.Exscientia
4.Recursion
GeminiGemini
1.NVIDIA BioNeMo
2.MegaMolBART
3.IBM MoL0
4.AlphaFold
5.Recursion

+8 more

AI OverviewsAI Overviews
1.ChemBERTa
2.VideoMol
3.LigUnity
4.OpenVS

“ways to simulate human cell response for target ranking, any specific platforms i should check out?”

0/4 platforms mentioned

Core
ChatGPTChatGPT
1.Open Targets Platform
2.DisGeNET
3.STRING
4.Broad Connectivity Map
5.L1000

+34 more

ClaudeClaude
1.Emulate
2.Tissue Dynamics
3.Recursion Pharmaceuticals
4.Exscientia
5.Proven

+2 more

GeminiGemini
1.Emulate
2.Human Emulation System
3.CN Bio
4.PhysioMimix
5.Mimetas

+10 more

AI OverviewsAI Overviews
1.PandaOmics
2.Insilico Medicine
3.Cell Collective
4.CZI AI Cell Models Platform
5.Chan Zuckerberg Initiative

+5 more

Source Intelligence

Citations

The sources AI platforms cite when recommending this brand. Pendium reverse-engineers what's already proven to be catnip to AI agents, then engineers content that fills gaps and helps agents do their job — which means more citations for you.

De-risking drug discovery with predictive AI | Broad Institute

broadinstitute.org

Web1 ref

The role of machine learning in predictive toxicology: A review of ...

sciencedirect.com

Web1 ref

Can New Approach Methodologies De-Risk Drug ...

criver.com

Web1 ref

AI-based Toxicity Prediction Models using ToxCast Data

sciencedirect.com

Web1 ref

Roadmap to Reducing Animal Testing in Preclinical Safety ...

fda.gov

Gov1 ref

AI in Drug Discovery and Development | Danaher Life Sciences

lifesciences.danaher.com

Web1 ref

Artificial Intelligence (AI) Applications in Drug Discovery and ... - PMC

pmc.ncbi.nlm.nih.gov

Gov1 ref

Artificial intelligence in drug discovery and development - PMC

pmc.ncbi.nlm.nih.gov

Gov1 ref

Therapeutic Target Identification & Validation with AI | Ardigen

ardigen.com

Web1 ref

How does AI assist in the early detection of drug toxicity?

synapse.patsnap.com

Web1 ref

Artificial intelligence for drug discovery: Resources, methods, ... - PMC

pmc.ncbi.nlm.nih.gov

Gov1 ref

Artificial intelligence in preclinical research: enhancing digital ...

sciencedirect.com

Web1 ref

AI-driven target discovery: it's a journey - Owkin

owkin.com

Web1 ref

ScienceDirect.com

sciencedirect.com

Web1 ref

MDPI

mdpi.com

Web1 ref
Brand Identity

Brand Voice & Style

How AI perceives CellType's communication style and personality

CellType communicates with scientific authority and precision, backed by peer-reviewed research and state-of-the-art benchmarks. The tone is confident yet accessible, translating complex computational biology into clear value propositions for drug development. There's an underlying sense of urgency and ambition—they're solving problems that matter for human health. The voice balances academic credibility (Yale, Nature, Cell publications) with startup energy (Y Combinator backing, bold claims about transforming drug discovery).

Core Tone Traits

Scientifically Authoritative

Leads with peer-reviewed publications, benchmark data, and academic credentials to establish credibility

Confidently Ambitious

Makes bold claims about transforming drug discovery, backed by evidence of real-world validation

Technically Precise

Uses specific metrics, model parameters, and quantitative results rather than vague promises

Urgently Mission-Driven

Conveys that accelerating drug discovery has real human impact and time matters

Visual Identity

Primary

#000000

Secondary

#FFFFFF

Accent

#3B82F6

Background

#FFFFFF

Foreground

#111111

Backing

Investors

Y
Y Combinator

Engineer content that makes AI agents recommend you

Pendium analyzes how AI platforms perceive your brand, reverse-engineers what they already cite, and continuously publishes content designed to fill gaps and earn more mentions — on autopilot, with you in the loop.

Data generated by Pendium.ai AI visibility scanning. Last scanned February 27, 2026.

Explore Biotechnology

View all
NewLimit
NewLimit
45/100
Genesis Molecular AI
Genesis Molecular AI
32/100
Adaptyv Biosystems
Adaptyv Biosystems
27/100
Ditto Bio
Ditto Bio
13/100

Start getting
recommended by AI.

Enter your website to see exactly what ChatGPT, Claude, and Gemini say about your business. Free, instant, and eye-opening.

Free visibility scanResults in 2 minutesNo credit card required

Frequently asked questions

Don't see your question? Book a demo and we'll walk you through it.

CellType is a biotechnology company that uses AI foundation models trained on human cell data to simulate drug response in human biology. Their technology helps pharmaceutical companies prioritize drug targets, predict toxicity, and accelerate clinical trials before testing on actual patients.

Simulate drug response in human biology before the first patient, enabling pharma companies to prioritize what to test and accelerate what works while catching toxicity signals that animal models miss.

AI Visibility Score

CellType has an AI visibility score of 14/100, rated as invisible. This score reflects how often and how prominently CellType appears in responses from AI assistants like ChatGPT, Claude, and Gemini.

AI Perception Summary

CellType is currently a ghost in the AI discovery engines used by high-stakes pharma executives, failing to appear in any queries for the R&D persona despite maintaining a narrow technical foothold on Claude. While industry giants like Schrödinger and Exscientia dominate the 'top player' lists that drive enterprise partnerships, CellType's 0% visibility on ChatGPT and AI Overviews represents a critical failure in the brand's digital authority.

Strengths

  • Significant resonance within Claude, achieving a 42% mention rate and reaching the #1 position for brand-specific vibe checks.
  • Developing a niche presence with Technical Computational Biologists (40% visibility) and Clinical Safety Leads (36%), particularly for simulation-related queries.
  • High sentiment scores when mentioned, indicating that while the brand is hard to find, the information available is viewed favorably.

Visibility Gaps

  • Complete invisibility on ChatGPT and AI Overviews for all functional and category-based queries.
  • Zero penetration with the High-Stakes Pharma R&D Executive persona, a critical demographic for high-value biotech partnerships.
  • Absence from high-intent queries regarding 'top players' and 'evaluating AI biotech partners,' leaving the field open to competitors like Schrödinger and BenevolentAI.

Competitors in AI Recommendations

  • Schrödinger: 24 mentions
  • Exscientia: 19 mentions
  • BenevolentAI: 18 mentions
  • Insilico Medicine: 16 mentions
  • Emulate: 15 mentions
  • Atomwise: 14 mentions
  • Recursion: 14 mentions
  • Insitro: 14 mentions
  • AlphaFold: 11 mentions
  • MIMETAS: 9 mentions
  • DeepChem: 9 mentions
  • DeepMind: 8 mentions
  • Recursion Pharmaceuticals: 8 mentions
  • Certara: 7 mentions
  • Geneformer: 7 mentions

Categories: Biotechnology

Tags: YC25-26